These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 12656664

  • 21. [Manifestations and prognosis of thyrotropin-secreting pituitary adenomas: a case series of three patients].
    Latrech H, Rousseau A, Le Marois E, Billaud L, Bertagna X, Azzoug S, Raffin-Sanson ML.
    Rev Med Interne; 2010 Dec; 31(12):858-62. PubMed ID: 21074296
    [Abstract] [Full Text] [Related]

  • 22. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T, Yokoyama N, Tamai M, Imaizumi M, Kimura H, Tominaga T, Ashizawa K, Kiriyama T, Yoshimine H, Ohishi K, Eguchi K.
    Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
    [Abstract] [Full Text] [Related]

  • 23. Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma.
    Skorić T, Korsić M, Zarković K, Plavsić V, Besenski N, Breskovac L, Giljević Z, Paladino J.
    Eur J Endocrinol; 1999 Jun; 140(6):528-37. PubMed ID: 10366409
    [Abstract] [Full Text] [Related]

  • 24. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment.
    Horiguchi K, Yamada M, Umezawa R, Satoh T, Hashimoto K, Tosaka M, Yamada S, Mori M.
    Endocr J; 2007 Jun; 54(3):371-8. PubMed ID: 17420609
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM, Arlot S, Lefebvre H, Caron P, Cortet-Rudelli C, Archambaud F, Chanson P, Tabarin A, Goth MI, Blumberg J, Catus F, Ispas S, Beck-Peccoz P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [Abstract] [Full Text] [Related]

  • 26. Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case.
    Ortiz E, Peldoza M, Monnier E, Gejman R, Henriquez M, Barra MI, Gayoso R, Sapunar J, Villaseca M, Guzmán P.
    Steroids; 2020 Feb; 154():108535. PubMed ID: 31704334
    [Abstract] [Full Text] [Related]

  • 27. Medical management of thyrotropin-secreting pituitary adenomas.
    Beck-Peccoz P, Persani L.
    Pituitary; 2002 Feb; 5(2):83-8. PubMed ID: 12675505
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of the long-acting octreotide formulation in patients with thyroid-stimulating hormone-secreting pituitary adenomas after incomplete surgery and octreotide treatment failure.
    Zhang CF, Liang D, Zhong LY.
    Chin Med J (Engl); 2012 Aug; 125(15):2758-63. PubMed ID: 22931988
    [Abstract] [Full Text] [Related]

  • 29. Thyrotropin-secreting pituitary adenomas.
    Beck-Peccoz P, Persani L, Mantovani S, Cortelazzi D, Asteria C.
    Metabolism; 1996 Aug; 45(8 Suppl 1):75-9. PubMed ID: 8769389
    [Abstract] [Full Text] [Related]

  • 30. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Aug; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 31. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
    Wynne AG, Gharib H, Scheithauer BW, Davis DH, Freeman SL, Horvath E.
    Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
    [Abstract] [Full Text] [Related]

  • 32. Thyrotropin-secreting pituitary adenomas: report of seven cases.
    Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
    [Abstract] [Full Text] [Related]

  • 33. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

  • 34. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J, De Tribolet N, Déruaz JP, Janzer R, Uské A, Mirimanoff RO, Reymond MJ, Rey F, Temler E, Gaillard RC, Gomez F.
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [Abstract] [Full Text] [Related]

  • 35. TSH producing pituitary tumor: biochemical diagnosis and long-term medical management with octreotide.
    Chayen SD, Gross D, Makhoul O, Glaser B.
    Horm Metab Res; 1992 Jan; 24(1):34-8. PubMed ID: 1612557
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
    Gatto F, Grasso LF, Nazzari E, Cuny T, Anania P, Di Somma C, Colao A, Zona G, Weryha G, Pivonello R, Ferone D.
    Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
    [Abstract] [Full Text] [Related]

  • 37. Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism.
    Grisoli F, Leclercq T, Winteler JP, Jaquet P, Guibout M, Diaz-Vasquez P, Hassoun J, Nayak R.
    Surg Neurol; 1986 Apr; 25(4):361-8. PubMed ID: 3952630
    [Abstract] [Full Text] [Related]

  • 38. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    De Herdt C, Philipse E, De Block C.
    Eur J Endocrinol; 2021 Jul 12; 185(2):R65-R74. PubMed ID: 34132199
    [Abstract] [Full Text] [Related]

  • 39. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ.
    J Clin Endocrinol Metab; 1994 Nov 12; 79(5):1416-23. PubMed ID: 7962337
    [Abstract] [Full Text] [Related]

  • 40. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
    Gannage MH, Maacaron C, Okais N, Halaby G.
    J Med Liban; 1997 Nov 12; 45(2):97-101. PubMed ID: 9289506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.